Assoc. prof. Yana Simova: COVID can cause cardiovascular problems

 In News

At the end of September, the European Society of Cardiology issued a scientific publication stating that the administration of HCQ is safe for a short-term treatment for patients with COVID-19 infection, regardless of the clinical setting of delivery, causing only modest prolongation and no directly attributable arrhythmic deaths, which fully confirms BCI’s results.

Read the full interview here in Bulgarian.

Recent Posts